National Comprehensive Cancer Network



About NCCN

Kidney/Testicular Cancers Panel - Disclosures as of 9/7/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Neeraj Agarwal, MD

None

None

None

None

8/3/2012

Clair Beard, MD

None

None

None

None

5/3/2013

Sam Bhayani, MD

None

None

None

None

8/19/2012

Graeme B. Bolger, MD

None

Novartis Pharmaceuticals Corporation;
Aveo Pharmaceuticals;
Pfizer Inc.

None

None

3/5/2013

Mark K. Buyyounouski, MD, MS

None

None

None

None

8/9/2012

Sam S. Chang, MD

None

None

None

None

8/6/2012

Toni K. Choueiri, MD

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
AVEO Pharmaceuticals, Inc.;
Pfizer Inc.

None

None

10/1/2012

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Shilpa Gupta, MD

None

None

None

None

8/15/2012

Steven L. Hancock, MD

None

None

None

None

1/26/2012

Eric Jonasch, MD

None

Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Aveo Pharmaceuticals;
Pfizer Inc.

None

None

10/6/2012

Jenny J Kim, MD

None

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.

None

None

2/28/2013

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Timothy M. Kuzel, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Alton Pharmaceuticals;
ARgos Therapeutics;
Biovex, Inc

Celgene Corporation;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Affymax;
Aveo Pharma;
Prometheus Laboratories

None

None

8/28/2012

Clayton Lau, MD

None

Covidien AG;
Intuitive Surgical, Inc.

None

None

10/1/2012

Ellis G. Levine, MD

TRACON Pharmaceuticals

None

UpToDate

None

8/15/2012

Daniel W. Lin, MD

None

None

None

None

4/8/2012

Kim A. Margolin, MD

None

None

None

None

4/3/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

M. Dror Michaelson, MD, PhD

Abbott Laboratories;
Eisai Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Aveo;
Pfizer Inc.

Millennium Pharmaceuticals, Inc.;
Acceleron;
Merrimack Pharmaceuticals;
Pfizer Inc.

None

None

8/7/2012

Robert J. Motzer, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Pfizer Inc.

None

None

12/14/2011

Thomas Olencki, DO

None

Genentech, Inc.;
Pfizer Inc.

None

None

3/4/2013

Roberto Pili, MD

Pfizer Inc.

Genentech, Inc.;
Genentech, Inc.;
Pfizer Inc.;
Pfizer Inc.;
Wyeth Pharmaceuticals;
Wyeth Pharmaceuticals

None

None

4/12/2013

Elizabeth R. Plimack, MD, MS

None

None

None

None

10/17/2012

Bruce G. Redman, DO

None

None

None

None

8/6/2012

Cary N. Robertson, MD

None

Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
EDAP TMS, Inc.;
Endo Pharmaceuticals

None

None

8/8/2011

Charles J. Ryan, MD

None

None

None

None

6/10/2011

Joel Sheinfeld, MD

None

None

None

None

8/7/2012

Kanishka Sircar, MD

None

None

None

None

11/8/2012

Bradley G. Somer, MD

None

None

None

None

4/4/2013

Jue Wang, MD

Celgene Corporation;
GlaxoSmithKline;
Pfizer Inc.

None

None

None

9/7/2012

Richard B. Wilder, MD

None

None

None

None

8/6/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved